Ipratropium bromide: Clinical Trials

4 trials of Ipratropium bromide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow Ipratropium bromide: new trials by email Literature Review of Ipratropium bromide trials Research Report on Ipratropium bromide

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Actuation Indicator Trial in Patients With COPD
Ipratropium bromide - Pulmonary Disease, Chronic Obstructive
Phase 3CompletedBoehringer Ingelheim1422009-06-012014-07-02
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Budesonide, albuterol, Ipratropium bromide - Asthma
Phase 3CompletedNorthwell Health952007-09-012016-01-21
Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Ipratropium bromide, Magnesium Sulfate - COPD Exacerbation
Phase 3CompletedUniversity of Monastir1242005-01-012010-06-03
Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease
Ipratropium bromide / Salbutamol, Placebo Inhalation solution, Ipratropium bromide - Pulmonary Disease, Chronic Obstructive
Phase 3CompletedBoehringer Ingelheim11182002-10-012014-06-27

Conditions studied

Pulmonary Disease, Chronic Obstructive (2)  ·  Asthma (1)  ·  Emergencies (1)

Sponsors

Boehringer Ingelheim (2)  ·  Northwell Health (1)  ·  University of Monastir (1)

Countries

United States (2)  ·  Tunisia (1)

Top investigators

Robert Silverman, MD (1)